page contents

Tag Archives: Remain

External risks remain key threat to developed Asia-Pacific economies

Fri, Feb 15, 2019 – 5:50 AM POSITIVE domestic drivers such as the strength of personal consumption and expansionary fiscal policies are likely to sustain economic growth in the Asia-Pacific region, albeit at a slower pace owing to challenging times ahead for the region in 2019. In particular, the continued rise of service-based industries such as financial services, technology, education ...

Read More »

Blockchain Gains Ground, But Hurdles Remain

PHOTO: John Cameron PwC’s 2018 survey on blockchain adoption in the enterprise revealed the technology was slowly gathering momentum. However, significant hurdles remain, mainly how enterprises can turn a technology that was essentially designed for financi… Blockchain Search Results

Read More »

Europe’s tech ecosystem: 2018 a record year for investment, but inclusion and diversity remain key challenges

The European tech ecosystem saw record levels of investment in 2018, with the software industry growing five times faster than the rest of Europe’s economy, according to a report by global venture capital firm Atomico. Four tech IPOs or direct listings of European tech companies reached valuations of more than $ 5bn on opening day, and three of the top ...

Read More »

Diffusion Pharmaceuticals Executes Successful NASDAQ Compliance Plan: Company Will Remain Listed on NASDAQ Stock Market

Diffusion Pharmaceuticals Executes Successful NASDAQ Compliance Plan: Company Will Remain Listed on NASDAQ Stock Market CHARLOTTESVILLE, Va., Jan 03, 2019 (GLOBE NEWSWIRE via COMTEX) — Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN), a cutting-edge biotechnology company developing new treatments for life-threatening medical conditions by improving the body’s ability to bring oxygen to the areas where it’s needed most, today announced it received ...

Read More »

Diffusion Pharmaceuticals Executes Successful NASDAQ Compliance Plan: Company Will Remain Listed on NASDAQ Stock Market

Diffusion Pharmaceuticals Executes Successful NASDAQ Compliance Plan: Company Will Remain Listed on NASDAQ Stock Market CHARLOTTESVILLE, Va., Jan 03, 2019 (GLOBE NEWSWIRE via COMTEX) — Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN), a cutting-edge biotechnology company developing new treatments for life-threatening medical conditions by improving the body’s ability to bring oxygen to the areas where it’s needed most, today announced it received ...

Read More »

Diffusion Pharmaceuticals Executes Successful NASDAQ Compliance Plan: Company Will Remain Listed on NASDAQ Stock Market

Diffusion Pharmaceuticals Executes Successful NASDAQ Compliance Plan: Company Will Remain Listed on NASDAQ Stock Market CHARLOTTESVILLE, Va., Jan 03, 2019 (GLOBE NEWSWIRE via COMTEX) — Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN), a cutting-edge biotechnology company developing new treatments for life-threatening medical conditions by improving the body’s ability to bring oxygen to the areas where it’s needed most, today announced it received ...

Read More »

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close